Seroquel, Atacand Lead AstraZeneca New Products; Prilosec Nears $6 Bil.

The anti-psychotic Seroquel is one of the fastest growing products in the AstraZeneca portfolio, with sales totaling $232 mil. in 1999, the company indicated at its 1999 operating results review Feb. 24 in London.

More from Archive

More from Pink Sheet